SCHEMBL887733

SCHEMBL887733

CCCCCCCC1(C(=O)O)CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.50
CETP P11597 4/20 0.49
CYP2C19 P33261 1/20 0.48
CYP4F2 P78329 2/20 0.46
CYP4A11 Q02928 2/20 0.46
PPARG P37231 6/20 0.39
PPARD Q03181 6/20 0.39
PPARA Q07869 6/20 0.39
HDAC11 Q96DB2 5/20 0.39
TSHR P16473 4/20 0.39
GPR84 Q9NQS5 4/20 0.39
ALDH1A1 P00352 2/20 0.39
TLR2 O60603 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
FABP4 P15090 2/20 0.39
PTPN1 P18031 2/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
SLC22A8 Q8TCC7 1/20 0.39
MEN1 O00255 1/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27621914 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL14673472 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL5520991 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL5512477 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL1264712 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL887781 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL482363 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL8034730 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL7258608 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11
SCHEMBL14673719 1.00 TBXAS1 (0.50) TBXAS1CETPCYP2C19CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12564879-B2 Copper paste for joining, method for manufacturing joined body, and joined body RESONAC CORPORATION (JP) 2026-03-03 US disclosed
US-20250387833-A1 METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE RESONAC CORP (JP) 2025-12-25 US disclosed
US-20250293091-A1 METHOD FOR PRODUCING SUBSTRATE HAVING THROUGH-SILICON VIAS, SUBSTRATE HAVING THROUGH-SILICON VIAS, AND COPPER PASTE FOR THROUGH-SILICON VIA FORMATION RESONAC CORPORATION (JP) 2025-09-18 US disclosed
EP-4618701-A1 METHOD FOR MANUFACTURING GLASS SUBSTRATE HAVING CONDUCTIVE VIA, METAL PASTE FOR FORMING THROUGH-GLASS VIA, AND GLASS SUBSTRATE HAVING CONDUCTIVE VIA Resonac Corporation (JP) 2025-09-17 EP disclosed
US-12354914-B2 Method for producing substrate having through-silicon vias, substrate having through-silicon vias, and copper paste for through-silicon via formation RESONAC CORPORATION (JP) 2025-07-08 US disclosed
CN-112673715-B Electronic component and method for manufacturing electronic component 株式会社力森诺科 2025-03-07 CN disclosed
WO-2024190406-A1 METHOD FOR MANUFACTURING SUBSTRATE WITH CONDUCTIVE VIA, AND METHOD FOR MANUFACTURING WIRING SUBSTRATE WITH CONDUCTIVE VIA 株式会社レゾナック 2024-09-19 WO disclosed
WO-2024190405-A1 METHOD FOR MANUFACTURING ELECTROCONDUCTIVE-VIA-EQUIPPED SUBSTRATE, ELECTROCONDUCTIVE-VIA-EQUIPPED SUBSTRATE, AND METAL PASTE 株式会社レゾナック 2024-09-19 WO disclosed
US-20240300055-A1 METAL PASTE FOR JOINING, JOINT, AND MANUFACTURING METHOD THEREFOR RESONAC CORPORATION (JP) 2024-09-12 US disclosed
US-20240181575-A1 COPPER PASTE FOR FORMING SINTERED COPPER PILLARS AND METHOD FOR PRODUCING BONDED BODY RESONAC CORPORATION (JP) 2024-06-06 US disclosed
US-20050084390-A1 Refrigerant compressor and friction control process therefor NISSAN MOTOR CO., LTD. 2005-04-21 US disclosed
US-20050082139-A1 Low-friction sliding member in transmission, and transmission oil therefor NISSAN MOTOR CO., LTD. 2005-04-21 US disclosed
US-20050064196-A1 Low-friction sliding member and low-friction sliding mechanism using same Martin, Jean 2005-03-24 US disclosed
CN-1598340-A Low-friction sliding member and low-friction sliding mechanism using same NISSAN MOTOR (JP) 2005-03-23 CN disclosed
EP-1510594-A2 Low-friction sliding member and low-friction sliding mechanism using same Nissan Motor Co., Ltd. (JP) 2005-03-02 EP disclosed
EP-1510692-A1 Refrigerant compressor and friction control process therefor NISSAN MOTOR COMPANY, LIMITED (JP) 2005-03-02 EP disclosed
EP-1508611-A2 Low-friction sliding member in transmission, and transmission oil therefor NISSAN MOTOR COMPANY, LIMITED (JP) 2005-02-23 EP disclosed
CN-1584329-A Refrigerant compressor and friction control method thereof NISSAN MOTOR (JP) 2005-02-23 CN disclosed
US-6197217-B1 EXHIBIT A NEGATIVE DIELECTRIC ANISOTROPY VALUE, HAVE AN EXTREMELY HIGH VOLTAGE HOLDING RATIO AND A LOW THRESHOLD VOLTAGE, SMALL DEPENDENCY ON TEMPERATURE, HARDLY EXHIBIT SMECTIC PHASE; EXCELLENT IN MISCIBILITY WITH OTHER LC'S CHISSO CORPORATION (JP) 2001-03-06 US disclosed
EP-0213146-B1 A METHOD FOR THE EXTENSION OF THE TEMPERATURE RANGE FOR THE SMECTIC A PHASE OF A BASE LIQUID CRYSTAL COMPOSITION MERCK PATENT GmbH (DE) 1992-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250387833-A1 METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE C5, C9, CUTA TBXAS1 4583/4885CETP 1026/4885CYP2C19 979/4885
US-12564879-B2 Copper paste for joining, method for manufacturing joined body, and joined body DCX, DNAJA2, DNAJA1 TBXAS1 2272/4885CETP 252/4885CYP2C19 495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.